Skip links

GSS EU Science Funding Gateway

Leveraging functional genomics to reveal novel targets for cancer treatment

HORIZON-MISS-2027-02-CANCER-01
Forthcoming
General information
ProgrammeHorizon Europe (HORIZON)
Programme divisionHorizon Europe Framework Programme (HORIZON); Global Challenges and European Industrial Competitiveness; Health
CallHORIZON-MISS-2027-02 (Supporting the implementation of the Cancer Mission)
Type of actionHORIZON-RIA HORIZON Research and Innovation Actions
Type of MGAHORIZON Action Grant Budget-Based
Deadline modelsingle-stage
Planned opening date10 February 2027
Deadline date16 September 2027
StatusForthcoming
OECD fieldsBiological sciences, Clinical medicine
EC cross-cutting prioritiesDigital Agenda, Artificial Intelligence
Cluster or programme partEU Missions (HORIZON-MISS)
Thematic communities (as in the COST Action Graph)Cancer, Open science and FAIR data
Beneficiary categories (GSS model, in training)Legal Entities, Researchers/Research Centers/Institutions, Small and Medium Enterprises (SMEs)
Topic description

Expected Outcome:

Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:

  • Researchers and health professionals gain a deeper understanding of the functional effects of tumour heterogeneity during cancer initiation and progression, supporting the identification of more precise and novel therapeutic targets.
  • Researchers, health professionals and innovators benefit from improved knowledge and tools to support the discovery and development of next generation genomically-informed cancer treatments.
  • Researchers, innovators, and professionals across disciplines and sectors contribute to the UNCAN.eu research data platform by ensuring data interoperability, and enabling sustainable access to newly developed digital tools and models for the analysis and management of multimodal clinical data.

Scope:

The proposed topic will contribute to the EU Cancer Mission objective of improving the understanding of cancer initiation and progression. Of particular interest for this topic are paediatric and adolescent cancers[1] , cancers with limited treatment options, refractory cancers, rare cancers or cancer types with low five-year survival rates. Proposals may include the design of exploratory mechanistic studies using longitudinal patient bio-samples, clinical proof-of-concept studies and/or observational and translational studies involving newly collected or existing data, as appropriate. Applicants are encouraged to leverage technological advances in functional genomics[2] and structural biology including but not limited to rapid gene sequencing, single-cell studies, spatial gene mapping, spatial transcriptomics, epigenetic profiling, liquid biopsies and functional precision oncology pipelines. The use of causal inference, computational modelling and/or artificial intelligence tools is encouraged for the collection, visualisation, analysis and management of large, complex, and heterogeneous data sets. Collaboration among different scientific disciplines, including healthcare professionals, is envisaged[3].

Applicants should address all of the following activities:

  • To identify and validate new targets for innovative therapeutic approaches, by developing experimental models[4] and technologies to access the functional effects of tumour temporal heterogeneity on disease initiation, progression and relapse.
  • To investigate the mechanisms underlying the interply between the tumor’s dynamic multi-omics characteristics, its microenvironment and patient specific factors[5] during disease initiation and progression. This includes elucidating the mechanisms of adaptive resistance to therapies, utilizing clinical data where appropriate[6].
  • To apply state-of-the-art approaches, tools and models to integrate and analyse FAIR (Findable, Accessible, Interoperable, Reusable) multimodal longitudinal patient data. These digital assets should be made available through the UNCAN.eu research platform. All datasets produced should be described with metadata records in the EU dataset catalogue of the European Health Data Space. The involvement of existing ESFRI research infrastructures offering life science resources[7] including biobanking options should be appropriately reflected in the proposal workplan.

Advantage should be taken to the extent possible of data and experience gained under current large-scale initiatives such as: the European 1M+ Genomes[8] and the European Cancer Imaging initiative[9] and others as appropriate. Successful proposals are expected to establish appropriate collaborations with the project UNCAN-CONNECT that is implementing the UNCAN.eu research platform[10].

Successful proposals will be asked to join the 'Understanding' project cluster of the Cancer Mission[11] and should include a budget for networking, attendance at meetings, and joint activities[12]. The Commission will facilitate coordination of these activities.

Applicants envisaging to include clinical studies should provide details in the dedicated annex using the template provided in the submission system.

[1] Age at first diagnosis 0-19 years

[2] The use of transcriptomics, proteomics, epigenomics, and metabolomics to understand gene function in a systems biology context

[3] Proposals should include an appropriate mix of stakeholders from various disciplines and sectors, including but not limited to medical doctors, health-IT experts, researchers, AI-experts, solution providers, academia and research institutes, EU research infrastructures and SMEs

[4] Any relevant preclinical or clinical model including but not limited to in silico, in vitro, in vivo or ex vivo models

[5] such as: genetic background, immune status, age, sex, and comorbidities

[6] applicants may build over existing clinically annotated patient cohorts and exploit current EU biobanks for sample access

[7] https://lifescience-ri.eu/home.html

[8] European '1+ Million Genomes' Initiative | Shaping Europe’s digital future

[9] European Cancer Imaging Initiative | Shaping Europe’s digital future

[10] https://cordis.europa.eu/project/id/101215206

[11] In order to address the objectives of the Cancer Mission, participants will collaborate in project clusters to leverage EU-funding, increase networking across sectors and disciplines, and establish a portfolio of Cancer Mission R&I and policy actions

[12] Examples of those activities are organising joint workshops, establishing best practices, joint communication or citizen engagement activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate. Proposals are not required to include details of these activities, as they will be defined during the grant agreement preparation and during the life of the project

Topic conditions and documents
">

General conditions

1. Admissibility conditions: Proposal page limit and layout

described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries

described in Annex B of the Work Programme General Annexes.

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other Eligibility Conditions

Subject to restrictions for the protection of European communication networks.

described in Annex B of the Work Programme General Annexes.

4. Financial and operational capacity and exclusion

described in Annex C of the Work Programme General Annexes.

5a. Evaluation and award: Award criteria, scoring and thresholds

described in Annex D of the Work Programme General Annexes.

5b. Evaluation and award: Submission and evaluation processes

The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12.

described in Annex F of the Work Programme General Annexes and the Online Manual.

5c. Evaluation and award: Indicative timeline for evaluation and grant agreement

described in Annex F of the Work Programme General Annexes.

6. Legal and financial set-up of the grants

The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.

described in Annex G of the Work Programme General Annexes.

Specific conditions

described in the specific topic of the Work Programme

Budget overview
Topic and type of actionBudget 2027 (EUR)StagesOpening dateDeadlineContributions (EUR)Indicative number of grants
HORIZON-MISS-2027-02-CANCER-03 - HORIZON-RIA HORIZON Research and Innovation Actions24 000 000single-stage10 February 202716 September 20277 000 000 to 9 000 0003
HORIZON-MISS-2027-02-CANCER-02 - HORIZON-IA HORIZON Innovation Actions20 000 000single-stage10 February 202716 September 20277 000 000 to 10 000 0003
HORIZON-MISS-2027-02-CANCER-06 - HORIZON-CSA HORIZON Coordination and Support Actions3 000 000single-stage10 February 202716 September 20273 000 0001
HORIZON-MISS-2027-02-CANCER-01 - HORIZON-RIA HORIZON Research and Innovation Actions32 323 812single-stage10 February 202716 September 20277 000 000 to 8 000 0004
HORIZON-MISS-2027-02-CANCER-05 - HORIZON-PCP HORIZON Pre-commercial Procurement26 000 000single-stage10 February 202716 September 20278 000 000 to 10 000 0003
HORIZON-MISS-2027-02-CANCER-04 - HORIZON-RIA HORIZON Research and Innovation Actions10 000 000single-stage10 February 202716 September 20275 000 000 to 7 000 0003
Partner search
On the EU Funding & Tenders portal

The portal lists the partner search announcements published for this topic: open the topic on the portal and go to "Partner search announcements".

Through the GSS community

No requests yet for this call.

Post a partner request for this call

Topic Q&As

Questions and answers published by the EC for this topic are on the portal: open the topic on the portal and go to "Topic Q&As".

Get support

Online Manual is your guide on the procedures from proposal submission to managing your grant.

Horizon Europe Programme Guide contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.

Funding & Tenders Portal FAQ – find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.

Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.

National Contact Points (NCPs) – get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (‘third-countries’).

Enterprise Europe Network – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.

IT Helpdesk – contact the Funding & Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

European IPR Helpdesk assists you on intellectual property issues.

CEN-CENELEC Research Helpdesk and ETSI Research Helpdesk – the European Standards Organisations advise you how to tackle standardisation in your project proposal.

The European Charter for Researchers and the Code of Conduct for their recruitment – consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.

Partner Search help you find a partner organisation for your proposal.

Keywords

Keywords

Anticancer therapyCancer and its biological basisEpigenetics and gene regulationGenomicscomparative genomicsfunctional genomics
Source

Content published by the European Commission on the EU Funding & Tenders portal, updated automatically.

This website uses cookies to improve your web experience.
Home
Account
Cart
Search
Explore
Drag